Scancell Holdings plc Stock
Stocks
SCLP
GB00BX8KRW34
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
12:35:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 89.00 GBX | -1.11% |
|
-4.30% | -10.10% |
| 10-09 | EARNINGS AND TRADING: Mincon says 2026 results to beat expectations | AN |
| 10-09 | Scancell Holdings plc Reports Earnings Results for the Full Year Ended April 30, 2026 | CI |
| Market Cap | 108M 144M 129M 119M 202M 13.64B 204M 1.43B 566M 7.15B 539M 527M 22.67B | P/E 2027 * |
-3.59x | P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 133M 178M 159M 147M 249M 16.87B 253M 1.76B 701M 8.84B 667M 652M 28.04B | EV / Sales 2027 * |
57.8x | EV / Sales 2028 * | - |
| Free-Float |
96.87% | Yield 2027 * |
-
| Yield 2028 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SCLP | Delayed | |
Deutsche Boerse AG
| SCP0 | Delayed | |
|
OTC Markets
| SCNL.D | Delayed |
Last Transcript: Scancell Holdings plc
| 1 day | -1.11% | ||
| 1 week | -4.30% | ||
| Current month | -5.32% | ||
| 1 month | -6.81% | ||
| 3 months | -7.68% | ||
| 6 months | -31.54% | ||
| Current year | -10.10% |
| 1 week | 88 |  | 95 |
| 1 month | 88 | | 96 |
| Current year | 88 | | 295 |
| 1 year | 88 | | 295 |
| 3 years | 72.6 | | 295 |
| 5 years | 72.6 | | 295 |
| 10 years | 1.12 | | 295 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Durrant
CEO | Chief Executive Officer | 69 | 2021-07-27 |
| Chief Executive Officer | 64 | 2024-11-17 | |
David Schilansky
DFI | Director of Finance/CFO | 50 | 2026-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Linda Durrant
BRD | Director/Board Member | 69 | 2010-11-16 |
Ursula Ney
BRD | Director/Board Member | 74 | 2019-10-22 |
Susan Davies
BRD | Director/Board Member | 64 | 2020-09-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 3,150,000 | 0.3038% | |
| 8/8/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 102,236 | 0.0099% | |
| 8/4/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 4,400,000 | 0.4244% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.11% | -4.30% | -11.00% | -32.83% | 146M | |
| -3.10% | -4.19% | +32.67% | +59.47% | 65.28B | |
| +0.33% | +0.33% | +10.16% | +78.07% | 54.57B | |
| +0.16% | +1.73% | +9.89% | +102.10% | 53.59B | |
| -0.75% | +1.38% | +24.89% | +50.91% | 45.03B | |
| -1.30% | -4.80% | +16.05% | +114.76% | 42.17B | |
| +1.26% | -5.26% | +221.12% | +900.64% | 39.42B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.71B | |
| +2.06% | -7.81% | +23.88% | -9.82% | 24.01B | |
| +1.11% | +15.18% | +60.27% | +49.33% | 26.5B | |
| Average | -0.22% | -0.58% | +39.89% | +135.73% | 38.34B | |
| Weighted average by Cap. | -0.42% | -0.59% | +42.41% | +153.29% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2.31M 3.07M 2.76M 2.55M 4.31M 292M 4.37M 30.51M 12.12M 153M 11.53M 11.28M 485M | - |
| Net income | -27.94M -37.18M -33.37M -30.81M -52.22M -3.53B -52.86M -369M -147M -1.85B -140M -137M -5.87B | - |
| Net Debt | 25.57M 34.03M 30.54M 28.2M 47.79M 3.23B 48.38M 338M 134M 1.69B 128M 125M 5.37B | - |
Employees
55
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | GBX 89.00 | -1.11% | 660,712 |
| 26-10-26 | GBX 90.00 | -1.10% | 135,248 |
| 26-10-23 | GBX 91.00 | 0.00% | 86,395 |
| 26-10-22 | GBX 91.00 | +0.89% | 66,057 |
| 26-10-21 | GBX 90.20 | -3.01% | 87,877 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8900GBP
Average target price
1.900GBP
Spread / Average Target
+113.48%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCLP Stock
Select your edition
All financial news and data tailored to specific country editions
